Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

72
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
72
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

462
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
462
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

61
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
61
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

60
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
60
Dementia01:30

Dementia

276
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
276
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

66
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suboptimal adherence to brain health recommendations in patients pursuing anti-amyloid antibody therapy for Alzheimer's disease: Report from the Brain Health Vital Signs project.

The journal of prevention of Alzheimer's disease·2026
Same author

Alzheimer Disease Biomarkers and Assisted Dying: When Diagnosis Becomes a Deadline.

JAMA·2026
Same author

Relative impact of multidomain lifestyle interventions on deficit accumulation frailty over 24 months in the U.S. POINTER trial.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

Annals On Call - Alzheimer Disease: A Diagnostic Challenge.

Annals of internal medicine·2026
Same author

The Certain Uncertainty of an Alzheimer Disease Diagnosis.

Annals of internal medicine·2026
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Nov 9, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K

Cognitive Impairment in Aging Physicians: Current Challenges and Possible Solutions.

Gayatri Devi1, Darren R Gitelman1, Daniel Press1

  • 1Park Avenue Neurology (GD), New York City, NY; Advocate Lutheran General Hospital (DRG), Chicago, IL; Beth Israel Deaconess Medical Center (DP), Boston, MA; and Brigham and Women's Hospital (KRD), Boston, MA.

Neurology. Clinical Practice
|April 12, 2021
PubMed
Summary

Aging physicians face cognitive impairment risks, impacting patient safety and careers. Early evaluation and confidential support are key for safe practice continuation or transition to other roles.

More Related Videos

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

13.9K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K

Related Experiment Videos

Last Updated: Nov 9, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

13.9K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K

Area of Science:

  • Geriatric Medicine
  • Medical Ethics
  • Neurology

Background:

  • Cognitive impairment poses significant risks for aging physicians, potentially compromising patient safety and physician careers.
  • Neurologists, occupational health specialists, and psychiatrists play crucial roles in assessing and managing cognitive decline in physicians.
  • The heterogeneity of cognitive disorders necessitates individualized approaches to physician support.

Purpose of the Study:

  • To address the risks and benefits associated with cognitive impairment in aging physicians.
  • To explore strategies for supporting physicians with cognitive impairment to practice safely.
  • To identify alternative meaningful options for physicians unable to continue clinical practice.

Main Methods:

  • Review of current literature on physician cognitive impairment.
  • Analysis of roles for neurologists, occupational health physicians, and psychiatrists.
  • Discussion of policy and individual evaluation considerations.

Main Results:

  • Aging physicians are a demographic at increased risk for cognitive impairment.
  • Confidential support and tailored precautions are essential for physicians with cognitive impairment to practice safely.
  • Understanding individual variability in cognitive decline is critical for effective management.

Conclusions:

  • Proactive assessment and management of cognitive impairment in aging physicians are vital for patient safety and career longevity.
  • Confidential support systems and flexible practice arrangements can facilitate continued safe practice.
  • Alternative career paths should be considered for physicians with significant cognitive impairment.